Biomark Diagnostics Inc. (FRA:20B)
Germany · Delayed Price · Currency is EUR 0.2760
0.00 (0.00%)
At close: Sep 15, 2026
Biomark Diagnostics Market Cap
Biomark Diagnostics has a market cap or net worth of €29.39 million as of September 15, 2026. Its market cap has increased by 38.45% in one year.
Market Cap
29.39M
Enterprise Value
29.69M
Revenue
17.14K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.28
ChartMarket Cap Chart
Since November 27, 2014, Biomark Diagnostics's market cap has increased from 28.50M to 29.39M, an increase of 3.14%. That is a compound annual growth rate of 0.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 29.39M | -9.79% |
| Dec 30, 2025 | 32.58M | 228.85% |
| Dec 30, 2024 | 9.91M | -19.08% |
| Dec 29, 2023 | 12.24M | 23.53% |
| Dec 30, 2022 | 9.91M | -23.89% |
| Dec 30, 2021 | 13.02M | 134.71% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.31B |
| Novogenia AG | 84.00M |
| 2invest AG | 43.64M |
| Vidac Pharma Holding | 20.55M |
| co.don AG | 360.77K |
| Paion AG | 335.28K |
| bioXXmed AG | 274.58K |
| MagForce AG | 91.72K |